These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 20595428)

  • 61. Early-onset schizophrenia and obsessive-compulsive disorder in a young man with Dandy-Walker variant.
    Papazisis G; Mastrogianni A; Karastergiou A
    Schizophr Res; 2007 Jul; 93(1-3):403-5. PubMed ID: 17478081
    [No Abstract]   [Full Text] [Related]  

  • 62. [Effectiveness and tolerability of addition of risperidone in obsessive-compulsive disorder with poor response to serotonin reuptake inhibitors].
    Arias Horcajadas F; Soto JA; García-Cantalapiedra MJ; Rodríguez Calvin JL; Morales J; Salgado M
    Actas Esp Psiquiatr; 2006; 34(3):147-52. PubMed ID: 16736387
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Treatment of obsessive-compulsive disorder in an adult].
    Kähkönen S; Holmberg N
    Duodecim; 2010; 126(11):1310-6. PubMed ID: 20681354
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effective use of olanzapine for obsessive-compulsive symptoms in a patient with bipolar disorder.
    Petrikis P; Andreou C; Bozikas VP; Karavatos A
    Can J Psychiatry; 2004 Aug; 49(8):572-3. PubMed ID: 15453108
    [No Abstract]   [Full Text] [Related]  

  • 65. Adjunctive quetiapine for serotonin reuptake inhibitor-resistant obsessive-compulsive disorder: a meta-analysis of randomized controlled treatment trials.
    Fineberg NA; Stein DJ; Premkumar P; Carey P; Sivakumaran T; Vythilingum B; Seedat S; Westenberg H; Denys D
    Int Clin Psychopharmacol; 2006 Nov; 21(6):337-43. PubMed ID: 17012980
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Reduced short-term obsessive-compulsive symptoms in schizophrenic patients treated with risperidone: a single-blind prospective study.
    Veznedaroglu B; Ercan ES; Kayahan B; Varan A; Bayraktar E
    Hum Psychopharmacol; 2003 Dec; 18(8):635-40. PubMed ID: 14696023
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Augmenting obsessive-compulsive disorder treatment: from brain to mind.
    Ressler KJ; Rothbaum BO
    JAMA Psychiatry; 2013 Nov; 70(11):1129-31. PubMed ID: 24026506
    [No Abstract]   [Full Text] [Related]  

  • 68. Risperidone and haloperidol augmentation of serotonin reuptake inhibitors in refractory obsessive-compulsive disorder: a crossover study.
    Li X; May RS; Tolbert LC; Jackson WT; Flournoy JM; Baxter LR
    J Clin Psychiatry; 2005 Jun; 66(6):736-43. PubMed ID: 15960567
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Clinical features of patients with obsessive-compulsive disorder showing different pharmacological responses].
    Sumitani S; Ueno S; Ishimoto Y; Taniguchi T; Tomotake M; Motoki I; Yamauchi K; Ohmori T
    Seishin Shinkeigaku Zasshi; 2006; 108(12):1282-92. PubMed ID: 17334085
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Clomipramine treatment of obsessive compulsive symptomatology in schizophrenic patients.
    Zohar J; Kaplan Z; Benjamin J
    J Clin Psychiatry; 1993 Oct; 54(10):385-8. PubMed ID: 7903293
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The improvement of obsessive- compulsive symptoms in a patient with schizophrenia treated with clozapine.
    Kumar S; Ng B; Howie W
    Psychiatry Clin Neurosci; 2003 Apr; 57(2):235-6. PubMed ID: 12667173
    [No Abstract]   [Full Text] [Related]  

  • 72. [Obsessive-compulsive disorders: how to recognize and treat them].
    Walh K; Kordon A; Hohagen F
    MMW Fortschr Med; 2005 Sep; 147(35-36):42-5. PubMed ID: 16180571
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Case series: Adderall augmentation of serotonin reuptake inhibitors in childhood-onset obsessive compulsive disorder.
    Owley T; Owley S; Leventhal B; Cook EH
    J Child Adolesc Psychopharmacol; 2002; 12(2):165-71. PubMed ID: 12188985
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Effects of tryptophan depletion on selective serotonin reuptake inhibitor-remitted patients with obsessive compulsive disorder.
    Hood SD; Broyd A; Robinson H; Lee J; Hudaib AR; Hince DA
    J Psychopharmacol; 2017 Dec; 31(12):1615-1623. PubMed ID: 29095069
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Effect of Ziprasidone Augmentation of Serotonin Reuptake Inhibitors in Treatment-Resistant Obsessive-Compulsive Disorder: A 12-Week, Open-Label Uncontrolled Preliminary Study.
    Bruno A; Pandolfo G; Cedro C; Gallo G; De Felice M; Zoccali RA; Muscatello MR
    Clin Neuropharmacol; 2016; 39(1):6-9. PubMed ID: 26757309
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Personality disorders].
    Kiriike N
    Ryoikibetsu Shokogun Shirizu; 2003; (38):469-72. PubMed ID: 12877028
    [No Abstract]   [Full Text] [Related]  

  • 77. Pregabalin augmentation in treatment-resistant obsessive-compulsive disorder.
    Oulis P; Mourikis I; Konstantakopoulos G
    Int Clin Psychopharmacol; 2011 Jul; 26(4):221-4. PubMed ID: 21460732
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Again and again--the obsessive circle can be broken].
    Rück C; Andersson EM; Andréewitch S; Bejerot S; Ivarsson T; Bates S; Lindefors N
    Lakartidningen; 2011 Apr 6-12; 108(14):798-801. PubMed ID: 21638920
    [No Abstract]   [Full Text] [Related]  

  • 79. [Case of obsessive-compulsive disorder associated with neuroleptics-induced deficit syndrome (NIDS): successfully treated by discontinuation of neuroleptics followed by SSRI].
    Machida N; Shiotsuka S; Semba J
    Seishin Shinkeigaku Zasshi; 2005; 107(7):667-73. PubMed ID: 16146185
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Augmentation of serotonin reuptake inhibitors in refractory obsessive-compulsive disorder using adjunctive olanzapine: a placebo-controlled trial.
    Bystritsky A; Ackerman DL; Rosen RM; Vapnik T; Gorbis E; Maidment KM; Saxena S
    J Clin Psychiatry; 2004 Apr; 65(4):565-8. PubMed ID: 15119922
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.